Axon Enterprise, Inc $AXON Stock Holdings Increased by Shell Asset Management Co.

Shell Asset Management Co. increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 28.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,480 shares of the biotechnology company’s stock after purchasing an additional 553 shares during the quarter. Shell Asset Management Co.’s holdings in Axon Enterprise were worth $2,053,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. TCTC Holdings LLC raised its holdings in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC lifted its position in shares of Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares in the last quarter. Banque Transatlantique SA acquired a new position in Axon Enterprise in the 1st quarter worth approximately $31,000. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise in the 1st quarter worth approximately $32,000. Finally, Flaharty Asset Management LLC acquired a new position in Axon Enterprise in the 1st quarter worth approximately $33,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Trading Up 1.8%

Shares of Axon Enterprise stock opened at $727.41 on Thursday. The stock has a market capitalization of $57.10 billion, a P/E ratio of 179.61, a price-to-earnings-growth ratio of 27.75 and a beta of 1.41. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company has a 50-day simple moving average of $756.79 and a 200 day simple moving average of $710.65. Axon Enterprise, Inc has a 12-month low of $422.21 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm’s revenue for the quarter was up 32.6% on a year-over-year basis. During the same quarter last year, the company posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently commented on AXON. Raymond James Financial reaffirmed an “outperform” rating and issued a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Piper Sandler began coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 price objective for the company. Northland Securities set a $800.00 price objective on shares of Axon Enterprise in a research note on Tuesday, August 5th. JMP Securities reaffirmed a “market outperform” rating and issued a $825.00 price objective on shares of Axon Enterprise in a research note on Monday, September 29th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a research note on Wednesday. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the firm’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 100 shares of the firm’s stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $752.54, for a total transaction of $75,254.00. Following the completion of the sale, the director owned 1,416 shares of the company’s stock, valued at $1,065,596.64. The trade was a 6.60% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 59,932 shares of company stock worth $45,115,616 over the last ninety days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.